Self-monitoring Blood Glucose Devices Market Size, By Product (Self-monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By Distribution Channel (T

Self-monitoring Blood Glucose Devices Market Size, By Product (Self-monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By Distribution Channel (Type 1 Diabetes Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics & Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032

Self-monitoring Blood Glucose Monitoring Devices Market is anticipated to garner substantial momentum during 2023–2032 owing to the constant technological innovations in self-monitoring blood glucose devices. Advancements in technology offer easier, more portable, and more convenient testing devices that are anticipated to increase its popularity among insulin-dependent diabetes patients.

Self-monitoring technologies for blood glucose monitoring have become mainstream as they have proven to be pragmatic and convenient for diabetic population. According to credible reports, by 2045, more than 700 million people across the world will have diabetes.

Overall, the self-monitoring blood glucose monitoring devices industry is segmented in terms of product, application, distribution channel, and region.

Based on the product, the self-monitoring blood glucose meters segment is estimated to grow at over 14.5% CAGR through 2032. The growth will be majorly due to the convenience offered by these meters in home settings. Besides, the ongoing launch of new products by the major giants will also positively influence segment expansion.

Considering the application, the type 1 diabetes segment is anticipated to be valued at over $2.4 billion by 2032. The rising need for continuous monitoring of blood glucose levels among patients with type 1 diabetes to manage the dosing, will generate significant market revenue. As per reports, there were more than 8.4 million individuals living with type 1 diabetes in 2021.

By distribution channel, the hospital pharmacies segment is slated to register strong growth during the estimated timeframe. The increasing prevalence of diabetes and high susceptibility in the elderly population, coupled with a rise in hospital visits to manage the disease, will drive segment adoption in the ensuing years. Besides, the availability of innovative and advanced self-monitoring blood glucose devices at hospital pharmacies will stimulate the segment growth potential.

Regionally, the Asia Pacific self-monitoring blood glucose monitoring devices market is anticipated to be valued at over USD 13 billion by 2032. Growing geriatric population base and constantly surging cases of diabetes in the region will offer lucrative growth opportunities to the SMBG device market. The presence of some leading industry players, who are constantly working on launching new products, will support regional expansion. In addition, increasing healthcare expenditure and government initiatives to reduce the burden of the disease will further drive the SMBG device demand.